Related Experiment Video
Updated: Mar 6, 2026
10:16
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
8.6K
Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies
1a Department of Medicine , Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg , Marburg , Germany.
COPD
|March 18, 2017
Summary
Alpha-1-antitrypsin deficiency (AATD) is a common genetic cause of lung and liver disease, often missed in patients with COPD. Early diagnosis through blood tests and clinical clues can lead to timely treatment and improved outcomes.
Area of Science:
- Pulmonology
- Genetics
- Hepatology
Background:
- Alpha-1-antitrypsin deficiency (AATD) is a frequent genetic disorder linked to liver and lung diseases.
- AATD is significantly underdiagnosed despite its association with chronic obstructive pulmonary disease (COPD).
- Investigating AATD is crucial in all patients presenting with COPD or abnormal spirometry results.
Purpose of the Study:
- To highlight the underdiagnosis of AATD.
- To emphasize the importance of clinical suspicion and diagnostic testing for AATD.
- To discuss current and emerging therapeutic strategies for AATD.
Main Methods:
- Diagnosis of AATD is laboratory-based, confirmed via blood testing.
- Clinical 'clues' can prompt suspicion and facilitate earlier diagnosis.
- Evaluation of emerging evidence for therapeutic interventions.
Main Results:
- AATD is a common, yet unrecognized, cause of lung disease.
- Active investigation is required to identify AATD in at-risk populations.
- Alpha-1-antitrypsin augmentation therapy is indicated for severe AATD with FEV1 ≤65% predicted.
Conclusions:
- Earlier diagnosis of AATD is achievable through heightened clinical awareness and targeted testing.
- Augmentation therapy and potentially other emerging treatments may slow disease progression.
- Addressing AATD is essential for managing a significant subset of patients with lung disease.
More Related Videos
Related Concept Videos
01:24Cystic Fibrosis: Management
593
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
593
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:29Chronic Pancreatitis II: Collaborative Care
447
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
447
01:26Atherosclerosis III: Management
532
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
532
01:29Acute Respiratory Failure-V
564
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
564
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K